Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users

American Journal of Gastroenterology

Volumn 103, Issue 10, 2008, Pages 2658-2659

  Ibáñez, Luisa ^a   Vidal, Xavier ^a   Laporte, Joan Ramon ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACECLOFENAC; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; KETOPROFEN; KETOROLAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROTON PUMP INHIBITOR;

DRUG EFFECT; HUMAN; LETTER; OSTEOARTHRITIS; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK REDUCTION; UPPER GASTROINTESTINAL BLEEDING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTROINTESTINAL HEMORRHAGE; HUMANS; PROTON PUMP INHIBITORS; RISK FACTORS; TREATMENT OUTCOME;

EID: 53149150203     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02074_9.x     Document Type: Letter

References (5)

1. Abraham NS, Hartman C, Castillo D, et al. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users. Am J Gastroenterol 2008 103 : 323 32.
2. Laporte JR, Ibáñez L, Vidal X, et al. Upper gastrointestinal bleeding associated with the the use of NSAIDs. Newer versus older agents. Drug Saf 2004 27 : 411 20.
3. Ibáñez L, Vidal X, Vendrell L, et al. Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 2006 23 : 235 42.
4. Chan FKL, Hung LCT, Suen BY, et al. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 2002 347 : 2104 10.
5. Lanas A, García-Rodríguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective COX-2 inhibitors, traditional non-aspirin NSAIDs, aspirin, and combinations. Gut 2006 1 : 1 20.